Resistance formation to nitro drugs in Giardia lamblia: No common markers identified by comparative proteomics

Ankarklev, 2010, Behind the smile: cell biology and disease mechanisms of Giardia species, Nat. Rev. Microbiol., 8, 413, 10.1038/nrmicro2317 Ansell, 2017, Transcriptomics indicates active and passive metronidazole resistance mechanisms in three seminal Giardia lines, Front. Microbiol., 8, 398, 10.3389/fmicb.2017.00398 Arguello-Garcia, 2015, An antioxidant response is involved in resistance of Giardia duodenalis to albendazole, Front. Microbiol., 6, 286, 10.3389/fmicb.2015.00286 Brauner, 2016, Distinguishing between resistance, tolerance and persistence to antibiotic treatment, Nat. Rev. Microbiol., 14, 320, 10.1038/nrmicro.2016.34 Brown, 1998, Anaerobic bacterial metabolism in the ancient eukaryote Giardia duodenalis, Int. J. Parasitol., 28, 149, 10.1016/S0020-7519(97)00172-0 Cabrera-Licona, 2017, Expression and secretion of the Giardia duodenalis variant surface protein 9B10A by transfected trophozoites causes damage to epithelial cell monolayers mediated by protease activity, Exp. Parasitol., 179, 49, 10.1016/j.exppara.2017.06.006 Cernikova, 2018, Five facts about Giardia lamblia, PLoS Pathog., 14, 10.1371/journal.ppat.1007250 Clark, 2002, Methods for cultivation of luminal parasitic protists of clinical importance, Clin. Microbiol. Rev., 15, 329, 10.1128/CMR.15.3.329-341.2002 Dan, 2000, Inhibition of pyruvate-ferredoxin oxidoreductase gene expression in Giardia lamblia by a virus-mediated hammerhead ribozyme, Mol. Microbiol., 36, 447, 10.1046/j.1365-2958.2000.01863.x Di Matteo, 2008, The O2-scavenging flavodiiron protein in the human parasite Giardia intestinalis, J. Biol. Chem., 283, 4061, 10.1074/jbc.M705605200 Einarsson, 2016, Coordinated changes in gene expression throughout Encystation of Giardia intestinalis, PLoS Neglected Trop. Dis., 10, 10.1371/journal.pntd.0004571 Emery-Corbin, 2018, Proteomic diversity in a prevalent human-infective Giardia duodenalis sub-species, Int. J. Parasitol., 48, 817, 10.1016/j.ijpara.2018.05.003 Emery, 2018, Differential protein expression and post-translational modifications in metronidazole-resistant Giardia duodenalis, GigaScience, 7, 10.1093/gigascience/giy024 Emery, 2015, Quantitative proteomic analysis of Giardia duodenalis assemblage A: a baseline for host, assemblage, and isolate variation, Proteomics, 15, 2281, 10.1002/pmic.201400434 Engel, 2014, A low-affinity penicillin-binding protein 2x variant is required for heteroresistance in Streptococcus pneumoniae, Antimicrob. Agents Chemother., 58, 3934, 10.1128/AAC.02547-14 Gargantini, 2012, Putative SF2 helicases of the early-branching eukaryote Giardia lamblia are involved in antigenic variation and parasite differentiation into cysts, BMC Microbiol., 12, 284, 10.1186/1471-2180-12-284 Gargantini, 2016, Antigenic variation in the intestinal parasite Giardia lamblia, Curr. Opin. Microbiol., 32, 52, 10.1016/j.mib.2016.04.017 Hemphill, 2013, Thiazolides, a novel class of anti-infective drugs, effective against viruses, bacteria, intracellular and extracellular protozoan parasites and proliferating mammalian cells, Antiinfective Agents, 11, 22, 10.2174/22113626130103 Huang, 2006, An updated review on Cryptosporidium and Giardia, Gastroenterol. Clin. N. Am., 35, 291, 10.1016/j.gtc.2006.03.006 Kulakova, 2006, Epigenetic mechanisms are involved in the control of Giardia lamblia antigenic variation, Mol. Microbiol., 61, 1533, 10.1111/j.1365-2958.2006.05345.x Leitsch, 2015, Drug resistance in the microaerophilic parasite Giardia lamblia, Curr. Trop. Med. Rep., 2, 128, 10.1007/s40475-015-0051-1 Leitsch, 2017, A review on metronidazole: an old warhorse in antimicrobial chemotherapy, Parasitology, 1 Leitsch, 2011, Pyruvate:ferredoxin oxidoreductase and thioredoxin reductase are involved in 5-nitroimidazole activation while flavin metabolism is linked to 5-nitroimidazole resistance in Giardia lamblia, J. Antimicrob. Chemother., 66, 1756, 10.1093/jac/dkr192 Leitsch, 2016, Evaluation of Giardia lamblia thioredoxin reductase as drug activating enzyme and as drug target, Int. J. Parasitol. Drugs Drug Resist, 6, 148, 10.1016/j.ijpddr.2016.07.003 Lloyd, 2003, Nitrosative stress induced cytotoxicity in Giardia intestinalis, J. Appl. Microbiol., 95, 576, 10.1046/j.1365-2672.2003.02008.x Ma'ayeh, 2015, Transcriptional profiling of Giardia intestinalis in response to oxidative stress, Int. J. Parasitol., 45, 925, 10.1016/j.ijpara.2015.07.005 Mastronicola, 2010, Flavohemoglobin and nitric oxide detoxification in the human protozoan parasite Giardia intestinalis, Biochem. Biophys. Res. Commun., 399, 654, 10.1016/j.bbrc.2010.07.137 Minenoa, 2003, Giardiasis: recent progress in chemotherapy and drug development, Curr. Pharmaceut. Des., 9, 841 Müller, 2013, New approaches for the identification of drug targets in protozoan parasites, Int. Rev. Cell Mol. Biol., 301, 359, 10.1016/B978-0-12-407704-1.00007-5 Müller, 2018, Physiological aspects of nitro drug resistance in Giardia lamblia, Int. J. Parasitol. Drugs Drug Resist., 8, 271, 10.1016/j.ijpddr.2018.04.008 Müller, 2008, Identification of differentially expressed genes in a Giardia lamblia WB C6 clone resistant to nitazoxanide and metronidazole, J. Antimicrob. Chemother., 62, 72, 10.1093/jac/dkn142 Müller, 2015, Comparative characterisation of two nitroreductases from Giardia lamblia as potential activators of nitro compounds, Int J Parasitol Drugs Drug Resist, 5, 37, 10.1016/j.ijpddr.2015.03.001 Müller, 2006, In vitro effects of thiazolides on Giardia lamblia WB clone C6 cultured axenically and in coculture with Caco2 cells, Antimicrob. Agents Chemother., 50, 162, 10.1128/AAC.50.1.162-170.2006 Müller, 2013, Metabolism of nitro drugs metronidazole and nitazoxanide in Giardia lamblia: characterization of a novel nitroreductase (GlNR2), J. Antimicrob. Chemother., 68, 1781, 10.1093/jac/dkt106 Müller, 2007, Characterization of Giardia lamblia WB C6 clones resistant to nitazoxanide and to metronidazole, J. Antimicrob. Chemother., 60, 280, 10.1093/jac/dkm205 Müller, 2016, Giardia, 93 Nash, 2001, Treatment of Giardia lamblia infections, Pediatr. Infect. Dis. J., 20, 193, 10.1097/00006454-200102000-00015 Nash, 2002, Surface antigenic variation in Giardia lamblia, Mol. Microbiol., 45, 585, 10.1046/j.1365-2958.2002.03029.x Nillius, 2011, Nitroreductase (GlNR1) increases susceptibility of Giardia lamblia and Escherichia coli to nitro drugs, J. Antimicrob. Chemother., 66, 1029, 10.1093/jac/dkr029 Plutzer, 2010, Giardia taxonomy, phylogeny and epidemiology: facts and open questions, Int. J. Hyg Environ. Health, 213, 321, 10.1016/j.ijheh.2010.06.005 Prucca, 2009, Antigenic variation in Giardia lamblia, Cell Microbiol., 11, 1706, 10.1111/j.1462-5822.2009.01367.x Prucca, 2008, Antigenic variation in Giardia lamblia is regulated by RNA interference, Nature, 456, 750, 10.1038/nature07585 Rafferty, 2010, Giardia lamblia encodes a functional flavohemoglobin, Biochem. Biophys. Res. Commun., 399, 347, 10.1016/j.bbrc.2010.07.073 Rivero, 2010, Long double-stranded RNA produces specific gene downregulation in Giardia lamblia, J. Parasitol., 96, 815, 10.1645/GE-2406.1 Squire, 2017, Cryptosporidium and Giardia in Africa: current and future challenges, Parasites Vectors, 10, 195, 10.1186/s13071-017-2111-y Su, 2007, Neomycin and puromycin affect gene expression in Giardia lamblia stable transfection, Mol. Biochem. Parasitol., 156, 124, 10.1016/j.molbiopara.2007.07.015 Townson, 1992, Induction of metronidazole and furazolidone resistance in Giardia, Trans. R. Soc. Trop. Med. Hyg., 86, 521, 10.1016/0035-9203(92)90095-T Tyanova, 2016, The Perseus computational platform for comprehensive analysis of (prote)omics data, Nat. Methods, 13, 731, 10.1038/nmeth.3901 Upcroft, 1999, Efficacy of new 5-nitroimidazoles against metronidazole-susceptible and -resistant Giardia, Trichomonas, and Entamoeba spp, Antimicrob. Agents Chemother., 43, 73, 10.1128/AAC.43.1.73 Upcroft, 1993, Drug resistance and Giardia, Parasitol. Today, 9, 187, 10.1016/0169-4758(93)90144-5 Upcroft, 1990, Drug resistance in Giardia intestinalis, Int. J. Parasitol., 20, 489, 10.1016/0020-7519(90)90196-T Upcroft, 1998, Drug resistance in Giardia: clinical versus laboratory isolates, Drug Resist. Updates, 1, 166, 10.1016/S1368-7646(98)80035-6 Vicente, 2009, Redox properties of the oxygen-detoxifying flavodiiron protein from the human parasite Giardia intestinalis, Arch. Biochem. Biophys., 488, 9, 10.1016/j.abb.2009.06.011 Zylberberg, 2017, Prevalence and predictors of Giardia in the United States, Dig. Dis. Sci., 62, 432, 10.1007/s10620-016-4447-0